Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer

Tristan M. Sissung*, John Deeken, Crystal R. Leibrand, Douglas K. Price, Sheryl Ehrlich, Seth M. Steinberg, David J. Liewehr, William Dahut, William D. Figg

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Aim: Metabolism and transport play major roles in life-long exposure to endogenous and exogenous carcinogens. We therefore explored associations between polymorphisms in absorption, distribution, metabolism and elimination genes and the risk and prognosis of castration-resistant prostate cancer (CRPC). Materials & methods: A total of 634 genotypes were tested in 74 patients using the Affymetrix DMETv1.0 platform. Results: No relation to risk was found. Three SNPs were associated with CRPC prognosis in Caucasians: ABCB11 rs7602171G>A (p = 0.003; n = 30; hazard ratio [HR]: 0.307), GSTP1 rs1799811C>T (p = 0.001; n = 38; HR: 0.254) and SLC5A6 rs1395 (p = 0.004; n = 35; HR: 3.15). Two other polymorphisms among Caucasians were associated with interesting trends: ABCB4 rs2302387C>T (p = 0.039) and ABCC5 rs939339A>G (p = 0.018). Conclusion: This exploratory study is the first to show that polymorphisms in several absorption, distribution, metabolism and elimination genes may be associated with CRPC prognosis.

Original languageEnglish
Pages (from-to)1979-1986
Number of pages8
JournalPharmacogenomics
Volume17
Issue number18
DOIs
StatePublished - Dec 2016
Externally publishedYes

Keywords

  • castration-resistant prostate cancer
  • genotype
  • metabolism
  • outcome
  • survival
  • transport

Fingerprint

Dive into the research topics of 'Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancer'. Together they form a unique fingerprint.

Cite this